|
⚲
|
| Keyboard |
| Satvat Ali J
✚
|
|
|---|---|
| CIK # | 0001619839, 0001621788 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001619839] | |
| 3 | [0001621788] | |
| 4 | [0001621788] | |
| 5 | [0001621788] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| BridgeBio Pharma LLC | |
| Satvat Ali J | |
| Coherus Oncology Inc | |
| IPI Legacy Liquidation Co | |
| Eidos Therapeutics Inc | |
| Satvat Ali J | |
| PRA Health Sciences Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
BridgeBio Pharma LLC BBIO
Stock Option (Right to Buy) · derivative
|
2025-06-20 | Grant | 8,425 | $0.00 | |
|
BridgeBio Pharma LLC BBIO
Common Stock
|
2025-06-20 | Grant | 6,589 | $0.00 | |
|
Coherus Oncology Inc CHRS
Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 112,000 | $0.00 | |
|
BridgeBio Pharma LLC BBIO
Stock Option (Right to Buy) · derivative
|
2024-12-30 | Option exercise | 39,851 | $0.00 | |
|
BridgeBio Pharma LLC BBIO
Stock Option (Right to Buy) · derivative
|
2024-12-30 | Option exercise | 39,851 | $0.00 | |
|
BridgeBio Pharma LLC BBIO
Common Stock
|
2024-12-30 | Option exercise | 39,851 | $26.21 | 1,044,495 |
|
BridgeBio Pharma LLC BBIO
Stock Option (Right to Buy) · derivative
|
2024-12-30 | Option exercise | 79,702 | $0.00 | |
|
BridgeBio Pharma LLC BBIO
Common Stock
|
2024-12-30 | Option exercise | 79,702 | $10.99 | 875,925 |
|
BridgeBio Pharma LLC BBIO
Common Stock
|
2024-12-30 | Option exercise | 39,851 | $16.68 | 664,715 |
|
BridgeBio Pharma LLC BBIO
Stock Option (Right to Buy) · derivative
|
2024-06-21 | Grant | 26,014 | $0.00 | |
|
BridgeBio Pharma LLC BBIO
Stock Option (right to buy) · derivative
|
2023-06-21 | Grant | 51,501 | $0.00 | |
|
BridgeBio Pharma LLC BBIO
Stock Option (right to buy) · derivative
|
2022-06-22 | Grant | 104,921 | $0.00 | |
|
BridgeBio Pharma LLC BBIO
Stock Option (right to buy) · derivative
|
2021-06-17 | Grant | 38,895 | $0.00 | |
|
Eidos Therapeutics Inc EIDX
Stock Option (Right to Buy) · derivative
|
2021-01-26 | Disposed to issuer | 21,528 | ||
|
BridgeBio Pharma LLC BBIO
Stock Option (Right to Buy) · derivative
|
2021-01-26 | Grant | 39,851 | $0.00 | |
|
BridgeBio Pharma LLC BBIO
Stock Option (Right to Buy) · derivative
|
2021-01-26 | Grant | 79,702 | $0.00 | |
|
BridgeBio Pharma LLC BBIO
Stock Option (Right to Buy) · derivative
|
2021-01-26 | Grant | 39,851 | $0.00 | |
|
Eidos Therapeutics Inc EIDX
Stock Option (Right to Buy) · derivative
|
2021-01-26 | Disposed to issuer | 21,528 | ||
|
Eidos Therapeutics Inc EIDX
Stock Option (Right to Buy) · derivative
|
2021-01-26 | Disposed to issuer | 43,056 | ||
|
BridgeBio Pharma LLC BBIO
Stock Option (right to buy) · derivative
|
2020-06-02 | Grant | 112,422 | $0.00 | |
| showing 20 of 48 most recent transactions | |||||